Ginnetti; Anthony

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ginnetti; Anthony.The latest application filed is for "pyrrolidine orexin receptor agonists".

Company Profile

2.17.17

Ginnetti; Anthony - Perkasie PA
GINNETTI; Anthony - West Point PA US
Ginnetti; Anthony - North Wales PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrrolidine Orexin Receptor Agonists App 20220144771 - Bogen; Stephane L. ; et al.	2022-05-12
Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20210008055 - Bell; Ian M. ; et al.	2021-01-14
Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20190275024 - Bell; Ian M. ; et al.	2019-09-12
Piperidinone carboxamide azaindane CGRP receptor antagonists Grant 9,833,448 - Bell , et al. December 5, 2	2017-12-05
Cathepsin cysteine protease inhibitors Grant 9,656,990 - Stachel , et al. May 23, 2	2017-05-23
Cathepsin cysteine protease inhibitors Grant 9,573,913 - Stachel , et al. February 21, 2	2017-02-21
Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20170027925 - Bell; Ian M. ; et al.	2017-02-02
Cathepsin Cysteine Protease Inhibitors App 20160355502 - Stachel; Shawn ; et al.	2016-12-08
Piperidinone carboxamide azaindane CGRP receptor antagonists Grant 9,499,545 - Bell , et al. November 22, 2	2016-11-22
Piperidinone carboxamide indane CGRP receptor antagonists Grant 9,499,541 - Bell , et al. November 22, 2	2016-11-22
Cathepsin Cysteine Protease Inhibitors App 20160244417 - Stachel; Shawn ; et al.	2016-08-25
Fused heterocyclic azaindane carboxamide CGRP receptor antagonists Grant 9,067,941 - Burgey , et al. June 30, 2	2015-06-30
Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20150031716 - Bell; Ian M. ; et al.	2015-01-29
Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20150005330 - Bell; Ian M. ; et al.	2015-01-01
Piperidinone carboxamide azaindane CGRP receptor antagonists Grant 8,912,210 - Bell , et al. December 16, 2	2014-12-16
Fused heterocyclic indane carboxamide CGRP receptor antagonists Grant 8,895,572 - Burgey , et al. November 25, 2	2014-11-25
Piperidinone carboxamide indane CGRP receptor antagonists Grant 8,883,807 - Bell , et al. November 11, 2	2014-11-11
Piperidinone carboxamide azaindane CGRP receptor antagonists Grant 8,754,096 - Bell , et al. June 17, 2	2014-06-17
P2X3, receptor antagonists for treatment of pain Grant 8,598,209 - Burgey , et al. December 3, 2	2013-12-03
Fused Heterocyclic Azaindane Carboxamide Cgrp Receptor Antagonists App 20130267541 - Burgey; Christopher S. ; et al.	2013-10-10
Fused Heterocyclic Indane Carboxamide Cgrp Receptor Antagonists App 20130261138 - Burgey; Christopher S. ; et al.	2013-10-03
Piperidinone Carboxamide Indane Cgrp Receptor Antagonists App 20130231358 - Bell; Ian M. ; et al.	2013-09-05
Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20120122900 - Bell; Ian M. ; et al.	2012-05-17
Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20120122899 - Bell; Ian M. ; et al.	2012-05-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.